The classification presumes a causal relationship between hypertension and heart involvement and between hypertension and kidney involvement, as the two conditions are linked by the term “with” in the Alphabetic Index. These conditions should be coded as related even in the absence of provider documentation explicitly linking them, unless the documentation clearly states the conditions are unrelated. For hypertension and conditions not specifically linked by relational terms such as “with,” “associated with” or “due to” in the classification, provider documentation must link the conditions in order to code them as related.
I82.890
BookmarkAcute embolism and thrombosis of other specified veins
Filed alongside this entry 777
under Syndrome
- 4H G11.5
- 5q minus NOS D46.C
- 22q13.3 deletion Q93.52
- 48,XXXX Q97.1
- 49,XXXXX Q97.1
- abnormal innervation H02.519
- abstinence, neonatal P96.1
- acid pulmonary aspiration, obstetric O74.0
- activated phosphoinositide 3-kinase delta syndrome [APDS] D81.82
- acute abdominal R10.0
- acute respiratory distress (adult) (child) J80
- Adair-Dighton Q78.0
- Adams-Stokes (-Morgagni) I45.9
- adiposogenital E23.6
- adrenogenital E25.9
- afferent loop NEC K91.89
- Aicardi-Goutières E79.81
- Alagille (-Watson) Q44.71
- Alder's D72.0
- Aldrich (-Wiskott) D82.0
- alien hand R41.4
- Alpha-gal Z91.014
- Alport Q87.81
- alveolar hypoventilation E66.2
- alveolocapillary block J84.10
- amyostatic (Wilson's disease) E83.01
- androgen insensitivity E34.50
- androgen resistance E34.50
- Angelman Q93.51
- ankyloglossia superior Q38.1
- antibody deficiency D80.9
- anticardiolipin (-antibody) D68.61
- antidepressant discontinuation T43.205
- antiphospholipid (-antibody) D68.61
- aortomesenteric duodenum occlusion K31.5
- apical ballooning (transient left ventricular) I51.81
- arcuate ligament I77.4
- argentaffin, argintaffinoma E34.09
- Arrillaga-Ayerza I27.0
- arterial tortuosity Q87.82
- arteriovenous steal T82.898
- Asherman's N85.6
- ataxia-telangiectasia G11.3
- auriculotemporal G50.8
- autoerythrocyte sensitization (Gardner-Diamond) D69.2
- autoimmune polyglandular E31.0
- autoimmune lymphoproliferative [ALPS] D89.82
- autoinflammatory M04.9
- Avellis' G46.8
- Axenfeld-Rieger Q13.81
- Ayerza (-Arrillaga) I27.0
- Babinski-Nageotte G83.89
- Bakwin-Krida Q78.5
- Bardet-Biedl Q87.83
- bare lymphocyte D81.6
- Barré-Guillain G61.0
- Barré-Liéou M53.0
- Barsony-Polgar K22.4
- Barsony-Teschendorf K22.4
- Barth E78.71
- Bartter's E26.81
- basal cell nevus Q87.89
- Basedow's E05.00
- basilar artery G45.0
- Batten-Steinert G71.11
- Beals Q87.40
- Beau's I51.5
- Beck's I65.8
- Benedikt's G46.3
- Béquez César (-Steinbrinck-Chédiak-Higashi) E70.330
- Berardinelli-Siep E88.12
- big spleen D73.1
- bilateral polycystic ovarian E28.2
- Birt-Hogg-Dube syndrome Q87.89
- Björck (-Thorsen) E34.09
- Blackfan-Diamond D61.01
- Blau M04.8
- blind loop K90.2
- blue sclera Q78.0
- blue toe I75.02
- Boder-Sedgewick G11.3
- Boerhaave's K22.3
- Borjeson Forssman Lehmann Q89.89
- Bouillaud's I01.9
- Bourneville (-Pringle) Q85.1
- Bouveret (-Hoffman) I47.9
- brachial plexus G54.0
- bradycardia-tachycardia I49.5
- brain (nonpsychotic) F09
- brain stem stroke G46.3
- Brandt's (acrodermatitis enteropathica) E83.2
- BRCA1-cancer predisposition QA1.790
- BRCA2-cancer predisposition QA1.791
- broad ligament laceration N83.8
- Brock's J98.11
- bronchiolitis obliterans J44.81
- bronze baby P83.88
- Brown-Sequard G83.81
- Brugada I49.81
- bubbly lung P27.0
- Buchem's M85.2
- Budd-Chiari I82.0
- bulbar (progressive) G12.22
- Bürger-Grütz E78.3
- Burke's K86.89
- Burnett's (milk-alkali) E83.52
- burning feet E53.9
- Bywaters' T79.5
- Call-Fleming I67.841
- cannabinoid hyperemesis R11.16
- cannabis hyperemesis R11.16
- carbohydrate-deficient glycoprotein (CDGS) E77.8
- carcinogenic thrombophlebitis I82.1
- carcinoid E34.00
- cardiac asthma I50.1
- cardiacos negros I27.0
- cardiofaciocutaneous Q87.89
- cardiopulmonary-obesity E66.2
- cardiorespiratory distress (idiopathic) , newborn P22.0
- carpal tunnel G56.0
- Cassidy (-Scholte) E34.09
- cat cry Q93.4
- cat eye Q92.8
- cauda equina G83.4
- celiac K90.0
- central pain G89.0
- cervical (root) M53.1
- cervicobrachial (diffuse) M53.1
- cervicocranial M53.0
- cervicodorsal outlet G54.2
- cervicothoracic outlet G54.0
- Céstan (-Raymond) I65.8
- Charcot's (angina cruris) (intermittent claudication) I73.9
- Charcot-Weiss-Baker G90.09
- CHARGE Q89.89
- Chédiak-Higashi (-Steinbrinck) E70.330
- chest wall R07.1
- Chiari's (hepatic vein thrombosis) I82.0
- Chilaiditi's Q43.3
- chondrocostal junction M94.0
- chondroectodermal dysplasia Q77.6
- chromosome 4 short arm deletion Q93.3
- chromosome 5 short arm deletion Q93.4
- Churg-Strauss M30.1
- Clarke-Hadfield K86.89
- Clerambault's automatism G93.89
- clinically isolated G37.9
- Clouston's (hidrotic ectodermal dysplasia) Q82.4
- clumsiness, clumsy child F82
- cluster headache G44.009
- Coffin-Lowry Q89.89
- cold injury (newborn) P80.0
- combined immunity deficiency D81.9
- compartment (deep) (posterior) (traumatic) T79.A0
- compression T79.5
- concussion F07.81
- congestion-fibrosis (pelvic) , female N94.89
- congestive dysmenorrhea N94.6
- Conn's E26.01
- connective tissue M35.9
- conus medullaris G95.81
- Costen's (complex) M26.69
- costochondral junction M94.0
- costoclavicular G54.0
- costovertebral E22.0
- craniovertebral M53.0
- cri-du-chat Q93.4
- crib death R99
- croup J05.0
- crush T79.5
- CTNNB1 Q87.88
- Curschmann (-Batten) (-Steinert) G71.11
- Cushing's E24.9
- cryopyrin-associated periodic M04.2
- cryptophthalmos Q87.0
- cystic duct stump K91.5
- cytokine release D89.839
- Dana-Putnam D51.0
- Danbolt (-Cross) (acrodermatitis enteropathica) E83.2
- Dandy-Walker Q03.1
- Danlos' Q79.60
- Degos' I77.89
- Déjérine-Roussy G89.0
- delayed sleep phase G47.21
- demyelinating G37.9
- depersonalization (-derealization) F48.1
- De Quervain E34.51
- de Toni-Fanconi (-Debré) E72.09
- de Vivo syndrome E74.810
- diabetes mellitus in newborn infant P70.2
- dialysis associated steal T82.898
- Diamond-Blackfan D61.01
- Diamond-Gardener D69.2
- DIC (diffuse or disseminated intravascular coagulopathy) D65
- di George's D82.1
- Dighton's Q78.0
- disequilibrium E87.8
- Döhle body-panmyelopathic D72.0
- dorsolateral medullary G46.4
- double athetosis G80.3
- Down Q90.9
- Dravet (intractable) G40.834
- Dresbach's (elliptocytosis) D58.1
- DRESS (drug rash with eosinophilia and systemic symptoms) D72.12
- Dressler's (postmyocardial infarction) I24.1
- drug rash with eosinophilia and systemic symptoms (DRESS) D72.12
- drug withdrawal, infant of dependent mother P96.1
- dry eye H04.12
- dumping (postgastrectomy) K91.1
- Dupré's (meningism) R29.1
- dysmetabolic X E88.810
- dyspraxia, developmental F82
- Eagle-Barrett Q79.4
- Ebstein's Q22.5
- ectopic ACTH E24.3
- eczema-thrombocytopenia D82.0
- Eddowes' Q78.0
- effort (psychogenic) F45.8
- Eisenmenger's I27.83
- Ehlers-Danlos Q79.60
- Ekman's Q78.0
- electric feet E53.8
- Ellis-van Creveld Q77.6
- empty nest Z60.0
- endocrine-hypertensive E27.0
- eosinophilia-myalgia M35.89
- Erdheim-Chester (ECD) E88.89
- Erdheim's E22.0
- erythrocyte fragmentation D59.4
- Evans D69.41
- exhaustion F48.8
- extrapyramidal G25.9
- eyelid-malar-mandible Q87.0
- Faber's D50.9
- facet M47.89
- facet joint M47.819
- facial pain, paroxysmal G50.0
- Fallot's Q21.3
- familial cold autoinflammatory M04.2
- familial eczema-thrombocytopenia (Wiskott-Aldrich) D82.0
- Fanconi (-de Toni) (-Debré) E72.09
- faulty bowel habit K59.39
- Feil-Klippel (brevicollis) Q76.1
- fertile eunuch E23.0
- Fiedler's I40.1
- first arch Q87.0
- fish odor E72.89
- Fisher's G61.0
- Fitz's K85.80
- Flajani (-Basedow) E05.00
- flush E34.09
- Foix-Alajouanine G95.19
- Fong's Q87.2
- food protein-induced enterocolitis (FPIES) K52.21
- foramen magnum G93.5
- Foster-Kennedy H47.14
- Foville's (peduncular) G46.3
- FOXG1 QA0.0151
- fragile X Q99.2
- Franceschetti Q75.4
- Friderichsen-Waterhouse A39.1
- Froin's G95.89
- frontal lobe F07.0
- Fukuhara E88.49
- Gaisböck's D75.1
- ganglion (basal ganglia brain) G25.9
- Gardner-Diamond D69.2
- gastrojejunal loop obstruction K91.89
- Gee-Herter-Heubner K90.0
- Gelineau's G47.419
- genito-anorectal A55
- Gerstmann-Sträussler-Scheinker (GSS) A81.82
- Gianotti-Crosti L44.4
- giant platelet (Bernard-Soulier) D69.19
- Gilles de la Tourette's F95.2
- Glass Q87.89
- Gleich's D72.118
- goiter-deafness E07.1
- Goldberg Q89.89
- Goldberg-Maxwell E34.51
- Good's D83.8
- Gopalan's (burning feet) E53.8
- Gorlin's Q87.89
- Gougerot-Blum L81.7
- Gouley's I31.1
- Gower's R55
- gray or grey (newborn) P93.0
- Gubler-Millard G46.3
- Guillain-Barré (-Strohl) G61.0
- Gulf war T75.830
- gustatory sweating G50.8
- Hadfield-Clarke K86.89
- Hamman's J98.19
- hand-foot L27.1
- hand-shoulder G90.89
- hantavirus (cardio)-pulmonary (HPS) (HCPS) B33.4
- Hao-Fountain (HAFOUS) Q87.87
- happy puppet Q93.51
- Harada's H30.81
- Hayem-Faber D50.9
- headache NEC G44.89
- Heberden's I20.89
- Hedinger's E34.01
- Hegglin's D72.0
- HELLP (hemolysis, elevated liver enzymes and low platelet count) O14.2
- hemolytic-uremic D59.30
- hemophagocytic, infection-associated D76.2
- Henoch-Schönlein D69.0
- hepatic flexure K59.89
- hepatopulmonary K76.81
- hepatorenal K76.7
- hepatourologic K76.7
- hereditary alpha tryptasemia D89.44
- Herter (-Gee) (nontropical sprue) K90.0
- Heubner-Herter K90.0
- Heyd's K76.7
- Hilger's G90.09
- histiocytic D76.3
- histiocytosis NEC D76.3
- HIV infection, acute B20
- Hoffmann-Werdnig G12.0
- Hollander-Simons E88.19
- Hoppe-Goldflam G70.00
- Horner's G90.2
- hungry bone E83.81
- hunterian glossitis D51.0
- Hunt's (herpetic geniculate ganglionitis) (neuralgia) B02.21
- Hutchinson's triad A50.53
- hyperabduction G54.0
- hyperammonemia-hyperornithinemia-homocitrullinemia E72.4
- hypereosinophilic (HES) D72.119
- hyperimmunoglobulin D M04.1
- hyperimmunoglobulin E (IgE) D82.4
- hyperkalemic E87.5
- hypermobility M35.7
- hypernatremia E87.0
- hyperosmolarity (see also, Diabetes, by type, with hyperosmolarity) E87.0
- hyperperfusion G97.82
- hypersplenic D73.1
- hypertransfusion, newborn P61.1
- hyperventilation F45.8
- hypoglycemic (familial) (neonatal) E16.2
- hypokalemic E87.6
- hyponatremic E87.1
- hypopituitarism E23.0
- hypoplastic left-heart Q23.4
- hypopotassemia E87.6
- hyposmolality E87.1
- hypotension, maternal O26.5
- hypothenar hammer I73.89
- hypoventilation, obesity (OHS) E66.2
- ICF (intravascular coagulation-fibrinolysis) D65
- iliotibial band M76.3
- immobility, immobilization (paraplegic) M62.3
- immune effector cell-associated neurotoxicity (ICANS) G92.00
- immune reconstitution D89.3
- immune reconstitution inflammatory [IRIS] D89.3
- immunity deficiency, combined D81.9
- impending coronary I20.0
- impingement, shoulder M75.4
- inappropriate secretion of antidiuretic hormone E22.2
- infantilism (pituitary) E23.0
- inferior vena cava I87.1
- inherited neoplasm predisposition syndrome of multiple systems, specified NEC QA1.798
- inspissated bile (newborn) P59.1
- institutional (childhood) F94.2
- insufficient sleep F51.12
- intermediate coronary (artery) I20.0
- intravascular coagulation-fibrinolysis (ICF) D65
- iodine-deficiency, congenital E00.9
- IRDS (idiopathic respiratory distress, newborn) P22.0
- IVC (intravascular coagulopathy) D65
- Ivemark's Q89.01
- Jackson's G83.89
- jaw-winking Q07.8
- Jervell-Lange-Nielsen I45.81
- jet lag G47.25
- Job's D71.8
- Joseph-Diamond-Blackfan D61.01
- jugular foramen G52.7
- Kabuki (type 1, due to KMT2D mutation) (type 2, due to KDM6A mutation) Q89.81
- Kanner's (autism) F84.0
- Kartagener's Q89.3
- Kelly's D50.1
- Kleefstra Q87.86
- Klein (e) -Levine G47.13
- Klippel-Feil (brevicollis) Q76.1
- König's K59.89
- Korsakoff (-Wernicke) (nonalcoholic) F04
- Kostmann's D70.0
- Krabbe's congenital muscle hypoplasia Q79.8
- lacunar NEC G46.7
- Lambert-Eaton G70.80
- Larsen's Q74.8
- Lassueur Graham-Little Piccardi L66.19
- Launois' E22.0
- Laurence-Moon Q87.84
- Lawrence E88.12
- Lemierre I80.8
- Lennox-Gastaut G40.812
- lenticular, progressive E83.01
- Leopold-Levi's E05.90
- Lev's I44.2
- Li-Fraumeni QA1.792
- Lichtheim's D51.0
- Lightwood's N25.89
- Lignac (de Toni) (-Fanconi) (-Debré) E72.09
- Likoff's I20.89
- limbic epilepsy personality F07.0
- liver-kidney K76.7
- lobotomy F07.0
- Loeys-Dietz Q87.A
- Löffler's J82.89
- long arm 18 or 21 deletion Q93.89
- long QT I45.81
- Louis-Barré G11.3
- lower radicular, newborn (birth injury) P14.8
- Luetscher's (dehydration) E86.0
- Lupus anticoagulant D68.62
- Lutembacher's Q21.19
- Lynch (due to EPCAM) (due to MLH1) (due to MSH2) (due to MSH6) (due to PMS2) QA1.71
- macrophage activation D76.1
- magnesium-deficiency R29.0
- Majeed M04.8
- Mal de Debarquement R42
- malabsorption K90.9
- Mallory-Weiss K22.6
- mandibulofacial dysostosis Q75.4
- maple-syrup-urine E71.0
- Marable's I77.4
- Marfan Q87.40
- Marie's (acromegaly) E22.0
- May (-Hegglin) D72.0
- McArdle (-Schmidt) (-Pearson) E74.04
- McQuarrie's E16.2
- meconium plug (newborn) P76.0
- MED13L (mediator complex subunit 13L) Q87.85
- median arcuate ligament I77.4
- mediator complex subunit 13L (MED13L) Q87.85
- Meekeren-Ehlers-Danlos Q79.6
- megavitamin-B6 E67.2
- Meige G24.4
- MELAS E88.41
- Mendelson's O74.0
- MERRF (myoclonic epilepsy associated with ragged-red fibers) E88.42
- metabolic E88.810
- metastatic carcinoid E34.00
- micrognathia-glossoptosis Q87.0
- midbrain NEC G93.89
- middle lobe (lung) J98.19
- middle radicular G54.0
- migraine G43.909
- Mikulicz' K11.8
- milk-alkali E83.52
- Millard-Gubler G46.3
- Miller-Dieker Q93.88
- Miller-Fisher G61.0
- Minkowski-Chauffard D58.0
- Mirizzi's K83.1
- MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy) E88.49
- monofixation H50.42
- Morel-Moore M85.2
- Morel-Morgagni M85.2
- Morgagni (-Morel) (-Stewart) M85.2
- Morgagni-Adams-Stokes I45.9
- Muckle-Wells M04.2
- mucocutaneous lymph node (acute febrile) (MCLS) M30.3
- multisystem inflammatory (in adults) (in children) M35.81
- Mounier-Kuhn Q32.4
- myasthenic G70.9
- myelodysplastic D46.9
- myeloid hypereosinophilic D72.118
- myelopathic pain G89.0
- myeloproliferative (chronic) D47.1
- myofascial pain M79.18
- Naffziger's G54.0
- nail patella Q87.2
- NARP (Neuropathy, Ataxia and Retinitis pigmentosa) E88.49
- neonatal abstinence P96.1
- nephrotic (congenital) N04.9
- neurologic neglect R41.4
- Nezelof's D81.4
- Niikawa-Kuroki Q89.81
- Nonne-Milroy-Meige Q82.0
- Nothnagel's vasomotor acroparesthesia I73.89
- obesity hypoventilation (OHS) E66.2
- oculomotor H51.9
- Ogilvie K59.81
- Oliver-McFarlane Q87.89
- oral allergy T78.19
- oral-facial-digital Q87.0
- Ormond's N13.5
- oro-facial-digital Q87.0
- os trigonum Q68.8
- Osler-Weber-Rendu I78.0
- osteoporosis-osteomalacia M83.8
- Osterreicher-Turner Q87.2
- oto-palatal-digital Q87.0
- outlet (thoracic) G54.0
- Owren's D68.2
- Paget-Schroetter I82.890
- paralytic G83.9
- Parinaud's H51.0
- paroxysmal facial pain G50.0
- Parry's E05.00
- Parsonage (-Aldren) -Turner G54.5
- patella clunk M25.86
- Paterson (-Brown) (-Kelly) D50.1
- pectoral girdle I77.89
- pectoralis minor I77.89
- pediatric acute-onset neuropsychiatric (PANS) D89.89
- pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) D89.89
- pediatric inflammatory multisystem M35.81
- Pelger-Huet D72.0
- pellagra-cerebellar ataxia-renal aminoaciduria E72.02
- pellagroid E52
- pelvic congestion-fibrosis, female N94.89
- penta X Q97.1
- perabduction I77.89
- periodic fever M04.1
- periodic fever, aphthous stomatitis, pharyngitis, and adenopathy [PFAPA] M04.8
- periurethral fibrosis N13.5
- Peutz-Jeghers Q85.89
- phantom limb (without pain) G54.7
- pharyngeal pouch D82.1
- Phelan-McDermid Q93.52
- Pickwickian E66.2
- PIE (pulmonary infiltration with eosinophilia) J82.89
- pigmentary pallidal degeneration (progressive) G23.0
- pineal E34.8
- pituitary E22.0
- plantar fascia M72.2
- plateau iris (post-iridectomy) (postprocedural) H21.82
- Plummer-Vinson D50.1
- pluricarential of infancy E40
- plurideficiency E40
- pluriglandular (compensatory) E31.8
- pneumatic hammer T75.21
- polyangiitis overlap M30.8
- polycarential of infancy E40
- polyglandular E31.8
- polysplenia Q89.09
- pontine NEC G93.89
- postbacterial fatigue G93.39
- postcardiotomy I97.0
- postcholecystectomy K91.5
- postcommissurotomy I97.0
- postconcussional F07.81
- postcontusional F07.81
- post-COVID (-19) U09.9
- postencephalitic F07.89
- post endometrial ablation N99.85
- post-polypectomy coagulation K91.89
- postgastrectomy (dumping) K91.1
- postgastric surgery K91.1
- postinfarction I24.1
- postinfectious fatigue G93.39
- postlaminectomy NEC M96.1
- postleukotomy F07.0
- postmastectomy lymphedema I97.2
- postmyocardial infarction I24.1
- postoperative NEC T81.9
- postpartum panhypopituitary (Sheehan) E23.0
- postpolio (myelitic) G14
- postthrombotic I87.009
- postvagotomy K91.1
- postvalvulotomy I97.0
- postviral NEC G93.31
- Potain's K31.0
- potassium intoxication E87.5
- Prader-Willi Q87.11
- Prader-Willi-like Q87.19
- precerebral artery (multiple) (bilateral) G45.2
- preinfarction I20.0
- preleukemic D46.9
- premature senility E34.8
- premenstrual dysphoric F32.81
- premenstrual tension N94.3
- Prinzmetal-Massumi R07.1
- prune belly Q79.4
- pseudoparalytica G70.00
- pseudo -Turner's Q87.19
- psycho-organic (nonpsychotic severity) F07.9
- PTEN (hamartoma) tumor Q85.81
- Putnam-Dana D51.0
- pyogenic arthritis, pyoderma gangrenosum, and acne [PAPA] M04.8
- pyramidopallidonigral G20.C
- QT interval prolongation I45.81
- rapid time-zone change G47.25
- Rasmussen G04.81
- Raymond (-Céstan) I65.8
- Raynaud's I73.00
- RDS (respiratory distress syndrome, newborn) P22.0
- reactive airways dysfunction J68.3
- Refsum's G60.1
- Reifenstein E34.52
- Rendu-Osler-Weber I78.0
- residual ovary N99.83
- resistant ovary E28.39
- restless legs G25.81
- restrictive allograft J4A.0
- retinoblastoma (familial) C69.2
- retroperitoneal fibrosis K68.2
- retroviral seroconversion (acute) Z21
- Reye's G93.7
- Ridley's I50.1
- Romano-Ward (prolonged QT interval) I45.81
- rotator cuff, shoulder M75.10
- rubella (congenital) P35.0
- Ruvalcaba-Myhre-Smith E71.440
- Rytand-Lipsitch I44.2
- salt-losing N28.89
- SATB2-associated Q87.89
- Scaglietti-Dagnini E22.0
- scalenus anticus (anterior) G54.0
- scapuloperoneal G71.09
- schizophrenic, of childhood NEC F20.9
- Schnitzler D47.2
- Scholte's E34.09
- Schroeder's E27.0
- Schüller-Christian C96.5
- Schwachman (-Diamond) D61.02
- Schwartz (-Jampel) G71.13
- Schwartz-Bartter E22.2
- scimitar Q26.8
- sclerocystic ovary E28.2
- Seitelberger's G31.89
- septicemic adrenal hemorrhage A39.1
- seroconversion, retroviral (acute) Z21
- serotonin G90.81
- serous meningitis G93.2
- severe acute respiratory (SARS) J12.81
- shaken infant T74.4
- shock (traumatic) T79.4
- shock-lung J80
- Shwachman (-Diamond) D61.02
- sick-euthyroid E07.81
- sideropenic D50.1
- Siemens' ectodermal dysplasia Q82.4
- Silfversköld's Q78.9
- Simons' E88.11
- sinus tarsi M25.57
- sinusitis-bronchiectasis-situs inversus Q89.3
- Sipple's E31.22
- sirenomelia Q87.2
- Sjögren M35.00
- Slocumb's E27.0
- slow flow, coronary I20.89
- Sluder's G44.89
- Smith-Magenis Q93.88
- Sneddon-Wilkinson L13.1
- Snyder-Robinson Q87.89
- Soto's Q87.3
- South African cardiomyopathy I42.89
- Spen's I45.9
- Spurway's Q78.0
- staphylococcal scalded skin L00
- Stein-Leventhal E28.2
- Stein's E28.2
- Stevens-Johnson syndrome L51.1
- Stewart-Morel M85.2
- Stickler Q89.89
- stiff baby Q89.89
- stiff man G25.82
- Stokes (-Adams) I45.9
- stone heart I50.1
- straight back, congenital Q76.49
- Sturge-Weber (-Dimitri) Q85.89
- subclavian steal G45.8
- subcoracoid-pectoralis minor G54.0
- subcostal nerve compression I77.89
- subphrenic interposition Q43.3
- suprarenal cortical E27.0
- supraspinatus M75.10
- Susac G93.49
- swallowed blood P78.2
- sweat retention L74.0
- Swyer Q99.1
- Symond's G93.2
- systemic inflammatory response (SIRS), of non-infectious origin (without organ dysfunction) R65.10
- tachycardia-bradycardia I49.5
- takotsubo I51.81
- TAR (thrombocytopenia with absent radius) Q87.2
- tarsal tunnel G57.5
- teething K00.7
- tegmental G93.89
- telangiectasic-pigmentation-cataract Q82.8
- temporomandibular joint-pain-dysfunction M26.62
- Terry's H44.2
- testicular feminization E34.51
- thalamic pain (hyperesthetic) G89.0
- thoracic outlet (compression) G54.0
- Thorson-Björck E34.09
- thrombocytopenia with absent radius (TAR) Q87.2
- thrombosis with thrombocytopenia D75.84
- thyroid-adrenocortical insufficiency E31.0
- Tietze's M94.0
- time-zone (rapid) G47.25
- Toni-Fanconi E72.09
- Touraine's Q79.8
- toxic shock A48.3
- transient left ventricular apical ballooning I51.81
- traumatic vasospastic T75.22
- Treacher Collins Q75.4
- triple X, female Q97.0
- trisomy Q92.9
- tropical wet feet T69.02
- Trousseau's I82.1
- tumor lysis (following antineoplastic chemotherapy) (spontaneous) NEC E88.3
- tumor necrosis factor receptor associated periodic (TRAPS) M04.1
- upward gaze H51.8
- uremia, chronic N18.9
- urethral N34.3
- urohepatic K76.7
- usher Q99.819
- vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic (VEXAS) M04.3
- vago-hypoglossal G52.7
- vanishing twin of one fetus or more O31.4
- vascular NEC in cerebrovascular disease G46.8
- vasoconstriction, reversible cerebrovascular I67.841
- vasomotor I73.9
- vasospastic (traumatic) T75.22
- vasovagal R55
- van Buchem's M85.2
- van der Hoeve's Q78.0
- VATER Q87.2
- velo-cardio-facial Q93.81
- vena cava (inferior) (superior) (obstruction) I87.1
- vertebro-basilar artery G45.0
- vertebrogenic (pain) M54.89
- VEXAS (vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic) M04.3
- Vinson-Plummer D50.1
- virus B34.9
- visceral larva migrans B83.0
- visual disorientation H53.8
- vitamin B6 deficiency E53.1
- vitreal corneal H59.01
- vitreous (touch) H59.01
- Vogt-Koyanagi H20.82
- Volkmann's T79.6
- von Hippel-Lindau Q85.83
- von Schroetter's I82.890
- Waldenström-Kjellberg D50.1
- Wallenberg's G46.3
- wasting (syndrome) due to underlying condition E88.A
- water retention E87.79
- Waterhouse (-Friderichsen) A39.1
- Weber-Gubler G46.3
- Weber-Leyden G46.3
- Weber's G46.3
- Wegener's M31.30
- Weingarten's (tropical eosinophilia) J82.89
- Weiss-Baker G90.09
- Werdnig-Hoffman G12.0
- Wermer's E31.21
- Werner's E34.8
- Wernicke-Korsakoff (nonalcoholic) F04
- Westphal-Strümpell E83.01
- whiplash S13.4
- whistling face Q87.0
- Wilkie's K55.1
- Wilkinson-Sneddon L13.1
- Williams Q93.82
- Wilson's (hepatolenticular degeneration) E83.01
- Wiskott-Aldrich D82.0
- Woakes' (ethmoiditis) J33.1
- Wright's (hyperabduction) G54.0
- X I20.9
- XXXX Q97.1
- XXXXX Q97.1
- XXXXY Q98.1
- XXY Q98.0
- Yao M04.8
- yellow nail L60.5
- Zahorsky's B08.5
- Zellweger syndrome E71.510
- Zellweger-like syndrome E71.541
Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.
How to use this page
Everything the published sources say about one code, on one page.
- Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
- Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
- Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
- Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
- Risk-model chips show which published CMS models map this code.
What this page does not do
- Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
- Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".
Exclusions19never code together
- certain conditions originating in the perinatal period (P04-P96)P04-P96
- certain infectious and parasitic diseases (A00-B99)A00-B99
- complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
- endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
- injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
- neoplasms (C00-D49)C00-D49
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
- systemic connective tissue disorders (M30-M36)M30-M36
- transient cerebral ischemic attacks and related syndromes (G45.-)G45.-
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes4
Official Guidelines24
ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.
Hypertension with heart conditions classified to I50.-, Heart failure, I51.4, Myocarditis, unspecified, I51.89, Other ill-defined heart diseases, and I51.9, Heart disease, unspecified, is assigned to a code from category I11, Hypertensive heart disease. Use additional code(s) from category I50, Heart failure, or I51, Complications and ill-defined descriptions of heart disease, to identify the heart condition. Hypertension with heart conditions classified to I51.5, Myocardial degeneration, or I51.7, Cardiomegaly, is assigned to a code from category I11, Hypertensive heart disease. No additional code is assigned to identify the specific heart condition. The same heart conditions (I50.-, I51.4-I51.7, I51.89, I51.9) with hypertension are coded separately if the provider has documented they are unrelated to the hypertension. The applicable hypertension code I10, Essential (primary) hypertension, or a code from category I15, Secondary hypertension, should be assigned. Sequence according to the circumstances of the admission/encounter.
Assign codes from category I12, Hypertensive chronic kidney disease, when both hypertension and a condition classifiable to category N18, Chronic kidney disease (CKD), are present. CKD should not be coded as hypertensive if the provider indicates the CKD is not related to the hypertension. The appropriate code from category N18 should be used as a secondary code with a code from category I12 to identify the stage of chronic kidney disease. See Section I.C.14. Chronic kidney disease. If a patient has hypertensive chronic kidney disease and acute renal failure, the acute renal failure should also be coded. Sequence according to the circumstances of the admission/encounter.
The codes in category I13, Hypertensive heart and chronic kidney disease, are combination codes that include hypertension, heart disease and chronic kidney disease. Assign codes from combination category I13, Hypertensive heart and chronic kidney disease, when there is hypertension with both heart and chronic kidney disease. If heart failure is present, assign an additional code from category I50 to identify the type of heart failure. The appropriate code from category N18, Chronic kidney disease, should be used as a secondary code with a code from category I13 to identify the stage of chronic kidney disease. See Section I.C.14. Chronic kidney disease. The Includes note at I13 specifies that the conditions included at I11 and I12 are included together in I13. If a patient has hypertension, heart disease and chronic kidney disease, then a code from I13 should be used, not codes from I11 or I12, For patients with both acute renal failure and chronic kidney disease, the acute renal failure should also be coded. Sequence according to the circumstances of the admission/encounter.
For hypertensive cerebrovascular disease, first assign the appropriate code from categories I60-I69, followed by the appropriate hypertension code.
Subcategory H35.0, Background retinopathy and retinal vascular changes, should be used along with a code from categories I10 – I15, in the Hypertensive diseases section, to include the systemic hypertension. The sequencing is based on the reason for the encounter.
Secondary hypertension is due to an underlying condition. Two codes are required: one to identify the underlying etiology and one from category I15 to identify the hypertension. Sequencing of codes is determined by the reason for admission/encounter.
Assign a code from category I16, Hypertensive crisis, for documented hypertensive urgency, hypertensive emergency or unspecified hypertensive crisis. Code also any identified hypertensive disease (I10- I15). The sequencing is based on the reason for the encounter.
Pulmonary hypertension is classified to category I27, Other pulmonary heart diseases. For secondary pulmonary hypertension (I27.1, I27.2-), code also any associated conditions or adverse effects of drugs or toxins. The sequencing is based on the reason for the encounter, except for adverse effects of drugs (See Section I.C.19.e.).
Resistant hypertension refers to blood pressure of a patient with hypertension that remains above goal in spite of the use of antihypertensive medications. Assign code I1A.0, Resistant hypertension, as an additional code when apparent treatment resistant hypertension, treatment resistant hypertension, or true resistant hypertension is documented by the provider. A code for the specific type of existing hypertension is sequenced first, if known.
Assign code R03.0, Elevated blood pressure reading without diagnosis of hypertension, unless patient has an established diagnosis of hypertension. Assign code O13.-, Gestational [pregnancy-induced] hypertension without significant proteinuria, or O14.-, Pre-eclampsia, for transient hypertension of pregnancy.
This diagnostic statement usually refers to an existing state of hypertension under control by therapy. Assign the appropriate code from categories I10-I15, Hypertensive diseases.
Uncontrolled hypertension may refer to untreated hypertension or hypertension not responding to current therapeutic regimen. In either case, assign the appropriate code from categories I10-I15, Hypertensive diseases.
ICD-10-CM has combination codes for atherosclerotic heart disease with angina pectoris. The subcategories for these codes are I25.11, Atherosclerotic heart disease of native coronary artery with angina pectoris and I25.7, Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris. When using one of these combination codes it is not necessary to use an additional code for angina pectoris. A causal relationship can be assumed in a patient with both atherosclerosis and angina pectoris, unless the documentation indicates the angina is due to something other than the atherosclerosis. If a patient with coronary artery disease is admitted due to an acute myocardial infarction (AMI), the AMI should be sequenced before the coronary artery disease. See Section I.C.9. Acute myocardial infarction (AMI)
Medical record documentation should clearly specify the cause- and-effect relationship between the medical intervention and the cerebrovascular accident in order to assign a code for intraoperative or postprocedural cerebrovascular accident. Proper code assignment depends on whether it was an infarction or hemorrhage and whether it occurred intraoperatively or postoperatively. If it was a cerebral hemorrhage, code assignment depends on the type of procedure performed.
Category I69 is used to indicate conditions classifiable to categories I60- I67 as the causes of sequela (neurologic deficits), themselves classified elsewhere. These “late effects” include neurologic deficits that persist after initial onset of conditions classifiable to categories I60-I67. The neurologic deficits caused by cerebrovascular disease may be present from the onset or may arise at any time after the onset of the condition classifiable to categories I60-I67. Codes from category I69, Sequelae of cerebrovascular disease, that specify hemiplegia, hemiparesis and monoplegia identify whether the dominant or nondominant side is affected. Should the affected side be documented, but not specified as dominant or nondominant, and the classification system does not indicate a default, code selection is as follows: • For ambidextrous patients, the default should be dominant. • If the left side is affected, the default is non-dominant. • If the right side is affected, the default is dominant.
Codes from category I69 may be assigned on a health care record with codes from I60-I67, if the patient has a current cerebrovascular disease and deficits from an old cerebrovascular disease.
ischemic attack (TIA) and cerebral infarction (Z86.73) Codes from category I69 should not be assigned if the patient does not have neurologic deficits. See Section I.C.21.4. History (of) for use of personal history codes
ST elevation myocardial infarction (NSTEMI) The ICD-10-CM codes for type 1 acute myocardial infarction (AMI) identify the site, such as anterolateral wall or true posterior wall. Subcategories I21.0-I21.2 and code I21.3 are used for type 1 ST elevation myocardial infarction (STEMI). Code I21.4, Non-ST elevation (NSTEMI) myocardial infarction, is used for type 1 non-ST elevation myocardial infarction (NSTEMI) and nontransmural MIs. If a type 1 NSTEMI evolves to STEMI, assign the STEMI code. If a type 1 STEMI converts to NSTEMI due to thrombolytic therapy, it is still coded as STEMI. For encounters occurring while the myocardial infarction is equal to, or less than, four weeks old, including transfers to another acute setting or a postacute setting, and the myocardial infarction meets the definition for “other diagnoses” (see Section III, Reporting Additional Diagnoses), codes from category I21 may continue to be reported. For encounters after the 4-week time frame and the patient is still receiving care related to the myocardial infarction, the appropriate aftercare code should be assigned, rather than a code from category I21. For old or healed myocardial infarctions not requiring further care, code I25.2, Old myocardial infarction, may be assigned.
Code I21.9, Acute myocardial infarction, unspecified, is the default for unspecified acute myocardial infarction or unspecified type. If only type 1 STEMI or transmural MI without the site is documented, assign code I21.3, ST elevation (STEMI) myocardial infarction of unspecified site.
provided If an AMI is documented as nontransmural or subendocardial, but the site is provided, it is still coded as a subendocardial AMI. See Section I.C.21.3. for information on coding status post administration of tPA in a different facility within the last 24 hours.
A code from category I22, Subsequent ST elevation (STEMI) and non- ST elevation (NSTEMI) myocardial infarction, is to be used when a patient who has suffered a type 1 or unspecified AMI has a new AMI within the 4 week time frame of the initial AMI. A code from category I22 must be used in conjunction with a code from category I21. The sequencing of the I22 and I21 codes depends on the circumstances of the encounter. Do not assign code I22 for subsequent myocardial infarctions other than type 1 or unspecified. For subsequent type 2 AMI assign only code I21.A1. For subsequent type 4 or type 5 AMI, assign only code I21.A9. If a subsequent myocardial infarction of one type occurs within 4 weeks of a myocardial infarction of a different type, assign the appropriate codes from category I21 to identify each type. Do not assign a code from I22. Codes from category I22 should only be assigned if both the initial and subsequent myocardial infarctions are type 1 or unspecified.
The ICD-10-CM provides codes for different types of myocardial infarction. Type 1 myocardial infarctions are assigned to codes I21.0- I21.4. Type 2 myocardial infarction (myocardial infarction due to demand ischemia or secondary to ischemic imbalance) is assigned to code I21.A1, Myocardial infarction type 2 with the underlying cause coded first, if applicable. Do not assign code I24.89, Other forms of acute ischemic heart disease, for the demand ischemia. If a type 2 AMI is described as NSTEMI or STEMI, only assign code I21.A1. Codes I21.01-I21.4 should only be assigned for type 1 AMIs. Acute myocardial infarctions type 3, 4a, 4b, 4c and 5 are assigned to code I21.A9, Other myocardial infarction type. The "Code also" and "Code first" notes should be followed related to complications, and for coding of postprocedural myocardial infarctions during or following cardiac surgery.
Dysfunction Coronary microvascular dysfunction (CMD) is a condition that impacts the microvasculature by restricting microvascular flow and increasing microvascular resistance. Code I21.B, Myocardial infarction with coronary microvascular dysfunction, is assigned for myocardial infarction with coronary microvascular disease, myocardial infarction with coronary microvascular dysfunction, and myocardial infarction with non-obstructive coronary arteries (MINOCA) with microvascular disease.
Index entries leading here5
Alongside this code1same parent — I82.89
Medications3
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.